Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2023-188015

Published: 2023

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

Journal Articles

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Blood (2023) 142 (Supplement 1): 5179.

https://doi.org/10.1182/blood-2023-185122

Published: 2023

Journal Articles

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2023-187049

Published: 2023

Journal Articles

Getting to Know the Molecular Landscape of R/R Chronic Myeloid Leukemia: NGS-Based Profiling of Myeloid Mutations Beyond BCR/ABL

Roberto Ovilla-Martínez, Pamela E Baez Islas, Carmen Alaez-Verson, Nishalle E Ramirez Muniz, Fernando Perez-Jacobo, Gabriel Barragan-Ibañez, Mercedes González, Jesus Manuel L Lopez Valles, Laura I Banda-García, Eduardo E. Reynoso, Gregorio Campos Cabrera, Uendy Perez-Lozano, Samanta Tingen Velarde, Yolanda Lugo-García, Ana Carolina Reynoso, Jose L. Alvarez, Hiram U Severino-Lugo, Gilberto Israel Barranco Lampón

Blood (2023) 142 (Supplement 1): 6361.

https://doi.org/10.1182/blood-2023-181162

Published: 2023

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6697–6698.

https://doi.org/10.1182/blood-2022-162389

Published: 2022

Journal Articles

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Seisha Alana Von Glasenapp Gossen, Humberto Martinez-Cordero, Luis Villela, Perla Rocio Colunga-Pedraza, Fernando Perez-Jacobo, Arianna Robles, Diego Fernando Garces PAZ, Henry Idrobo, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Ana Carolina Oliver, Victoria Irigoin, Juan Alejandro Ospina, Rosa Oliday Rios

Blood (2022) 140 (Supplement 1): 9429–9430.

https://doi.org/10.1182/blood-2022-171102

Published: 2022

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 10918–10920.

https://doi.org/10.1182/blood-2022-168276

Published: 2022

Journal Articles

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Sofia Grille, Elvira DRP Velloso, Matilde Boada, Elia Apodaca Chavez, Andres Gomez-De Leon, Anna Cecilia Rodríguez-Zuñiga, Emmanuel Martínez Moreno, Fernando Perez-Jacobo, Graciela Alfonso, Juan Carlos Serrano, Natalia Tejeira, Lilián Díaz, Valentina Olivares, Laura Kornblihtt, Sergio Schusterschitz, Marcelo Iastrebner

Blood (2022) 140 (Supplement 1): 4096–4097.

https://doi.org/10.1182/blood-2022-168893

Published: 2022

Journal Articles

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Blood (2021) 138 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2021-153875

Published: 2021

Journal Articles

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2021-152724

Published: 2021

Journal Articles

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Blood (2021) 138 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2021-149662

Published: 2021

Journal Articles

Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-140631

Published: 2020

Journal Articles

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Luis Villela Villela, MDMC, Ana Ramirez-Ibarguen, MD, Brady E Beltran, MD, Camila Peña, MD, Denisse A. Castro, MD, Gladys P Agreda-Vasquez, MD, Myrna Candelaria, MDPharmD, Maria Alejandra Torres Viera, MD, Henry Idrobo, MD, Lorena Fiad, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Juan Ospina Idarraga, Alana Von Glasenapp, MD, Sally Paredes, MD, Melani Otañez, MD, Fernando Perez-Jacobo, Daniela Zambrano, Humberto Martínez Cordero, MD, Virginia Otero, MD, Lidiane Andino, Mercedes Royg Arriola, MD, Maria Elvira Enciso, MD, Maria Prates, MD, Cristaldo Nancy, MD, Ivan Perdomo, MD, Maria E Cabrera, MD, María Lorena Cardozo, MD, Cristobal Augusto Frutos Ortiz, MD, Eloisa Riva, MD, Juan Antonio Choque, MD, Alfredo Reinaldo Quiroz, MD, Guilherme Fleury Perini, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Marcos Distefano, Katerine Garcia, Carolina Feres, MD, Mariana Kalmus, Julian Cordova, Magali DelosRios, MD, Rosio Baena, MD, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-142836

Published: 2020

Journal Articles

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141943

Published: 2020

Journal Articles

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

Guilherme Fleury Perini, MD, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, MD, Brady E Beltran, MD, Denisse A. Castro, MD, Victoria Otero, MD, Mariana Kalmus, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Myrna Candelaria, MDPharmD, Alana Von Glasenapp, MD, Ivan Perdomo, MD, Carolina Feres, MD, Maria Prates, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, Claudia Gajardo, MD, Macarena Alejandra Roa Salinas, Humberto Martínez Cordero, MD, Melani Otañez, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Marcos Di Stefano, MD, Rosio Baena, MD, Juan Antonio Choque, MD, Virginia Abello, MD, Ximena Valladares, MD, Sofia Sanchez, MD, Cristaldo Nancy, MD, Daniela Zambrano, Juan Felipe Lasso, MD, Andrea Noboa, MD, Christine Rojas, MD, Larissa LC Teixeira, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD, Luis Villela Villela, MDMC

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142787

Published: 2020

Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Blood (2019) 134 (Supplement_1): 4121.

https://doi.org/10.1182/blood-2019-127479

Published: 2019

Journal Articles

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Blood (2019) 134 (Supplement_1): 1613.

https://doi.org/10.1182/blood-2019-123841

Published: 2019

Journal Articles

Treatment with Novel Agents in Patients with Multiple Myeloma in México: Data of Characteristics, Treatment Patterns and Outcomes from a Health Care System

Fernando Pérez-Jacobo, MD, Elia Zamora P., MD, Irma Leticia Barrios-Hernández, MD, Nubia Paloma Pérez-Mar, MD, Lidia Mondragón-Posadas, MD, Patricia Galindo-Delgado, MD, Magdalena Bahena-García, MD, Adrian Hernández-López, MD

Blood (2019) 134 (Supplement_1): 5562.

https://doi.org/10.1182/blood-2019-127582

Published: 2019

NARROW

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Getting to Know the Molecular Landscape of R/R Chronic Myeloid Leukemia: NGS-Based Profiling of Myeloid Mutations Beyond BCR/ABL

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Treatment with Novel Agents in Patients with Multiple Myeloma in México: Data of Characteristics, Treatment Patterns and Outcomes from a Health Care System

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only